Efficacy of gefitinib in a patient with lung cancer associated with idiopathic pulmonary fibrosis.
Kishi
Kazuma
K
Nakata
Koichiro
K
Yoshimura
Kunihiko
K
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D008207:Lymphatic Metastasis; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011658:Pulmonary Fibrosis / Q000150:complications*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib